Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
› More search options
Dr Aleksandra Gentry-Maharaj
MRC CTU at UCL
90 High Holborn, 2nd Floor
London
WC1V 6LJ
Appointment
- Senior Research Associate
- MRC Clinical Trials Unit at UCL
- Inst of Clinical Trials &Methodology
- Faculty of Pop Health Sciences
Biography
Joined the Gynaecological Cancer Research Centre as a Research Associate in 2003, first based at Barts and since April 2004 at UCL. Senior Research Associate since 2010. Most recently taken on the role of UKCTOCS Trial Manager. Moved to the MRC CTU at UCL in August 2018.
Alex has presented her work at national and key international meetings (ESGO Istanbul 2005, IGCS Santa Monica 2006, ESGO Berlin 2007, IMS Madrid 2008, ESGO Nice 2015).
Over the past decade, Alex has been invited to give talks at a number of international meetings: Controversies of Ovarian Cancer Screening, University of Geneva (2009), 2nd Sino-Euro Experts Conference on Immune Biomarkers for Personalized Medicine in Oncology, Fudan University Shanghai Cancer Center, Shanghai (2015), Ovarian Cancer Academy, Cluj-Napoca, Romania (2015), Université catholique de Louvain UCLouvain, Brussels (2016), Multidisciplinary Approach to Gynecological Cancers conference, Krakow (2017).
Research Themes
See More
See LessResearch Summary
Main interest in ovarian and endometrial cancer screening. Alex is part of the core team of the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), a randomised controlled trial involving 202,638 women from the UK assessing the mortality impact of screening. She has also been involved in the International Ovarian Cancer Association Consortium (OCAC) looking at genetic predisposition to ovarian cancer and has contributed to a number of publications in this field. Alex has an interest in the menopause transition and the therapies that women use to alleviate their menopausal symptoms. Other interests include biomarker discovery for ovarian as well as other cancers.
Teaching Summary
Alex has been involved in teaching on the MSc Reproductive Health course since 2008.
Currently, co-lead for the following modules:
* Women's Cancers module on the iBSc Women's Heath programme
* Concept and Controversies module on the newly established MSc Women's Health
* Applying Clinical Trial Design Principles in Practice module on the MSc Clinical Trials
Academic Background
| 2002 | PhD | Doctor of Philosophy – Cancer Research/Molecular Biology | King's College London |
| 1998 | MSc | Master of Science – Immunology | St George's Hospital Medical School |
| 1996 | Ba.BiomedScH | Bachelor Biomedical Science (Honours) – Biomedical Sciences | University of Westminster |
